Get startedLog in
    Picture of Apontis Pharma AG logo

    APPH — Apontis Pharma AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: Apontis Pharma Says Withdraws Forecast For Fiscal Year 2023 And Medium-Term Planning For 2026

    Picture of Apontis Pharma AG logoApontis Pharma AG
    27/07/2023 21:18
    July 27 (Reuters) - Apontis Pharma Ag  APPHG.DE :
    * EQS-NEWS: APONTIS PHARMA AG WITHDRAWS FORECAST FOR FISCAL
YEAR
2023 AND MEDIUM-TERM PLANNING FOR 2026 – PREPARATION OF PROGRAM
TO INCREASE OPERATING PERFORMANCE AND EFFICIENCY LAUNCHED
    * H1 PRELIMINARY EBITDA LOSS 4.0 MILLION EUR VERSUS 3.2
MILLION
EUR PROFIT YEAR AGO
    * H1 REVENUE 19.1 MILLION EUR
    * EBITDA FOR FULL YEAR 2023 ADDITIONALLY BURDENED BY ONE-OFF
EFFECTS FROM CHANGE IN MANAGEMENT BOARD
    * APONTIS PHARMA- FULL YEAR EBITDA IS ADDITIONALLY BURDENED
BY
ONE-OFF EFFECTS IN CONNECTION WITH RESIGNATION OF PREVIOUS CEO
OF ABOUT EUR 813 THOUSAND

Source text for Eikon:  ID:nEQ6MNblta 
Further company coverage:  APPHG.DE 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Apontis Pharma AG

    See all news